STOCK TITAN

Destination XL Group, Inc. Appoints Current Chairman Lionel Conacher as Interim Chief Executive Officer

(Moderate)
(Very Positive)
Tags

Destination XL Group (NASDAQ: DXLG) appointed current Board Chairman Lionel Conacher as Interim Chief Executive Officer, effective August 12, 2026, following the previously announced retirement of CEO Harvey Kanter on August 11, 2026. Kanter will also leave the Board.

Conacher will remain Board Chairman while stepping down as Audit Committee Chair and Compensation Committee member. According to Destination XL, he will help oversee execution of its profitability strategy and support work on its FiTMAP rollout, AI investments and response to increasing GLP‑1 usage, as well as navigate the pending FullBeauty merger and Zodiac Partners’ unsolicited tender offer. The Board has appointed Carmen Bauza as Lead Independent Director under the company’s corporate governance guidelines.

Loading...
Loading translation...

Positive

  • Chairman named Interim CEO effective August 12, 2026, providing leadership continuity
  • Interim CEO brings prior M&A and interim CEO experience relevant to FullBeauty merger and tender offer
  • Carmen Bauza appointed Lead Independent Director in line with corporate governance guidelines

Negative

  • Long‑tenured CEO Harvey Kanter retires and leaves the Board on August 11, 2026
  • Leadership transition occurs while FullBeauty merger and Zodiac Partners unsolicited tender offer are pending

News Explained

The board says it will conduct a search for the next leader, leaving Lionel Conacher’s appointment explicitly interim rather than a permanent CEO selection.

Market Context

DXLG’s recent news record included a -2.62% 24-hour reaction to news_id 1083674. That history puts t...
Analysis

DXLG’s recent news record included a -2.62% 24-hour reaction to news_id 1083674. That history puts the interim CEO appointment in a broader governance context; the leadership search and low short positioning remained relevant watchpoints.

Key Figures

Interim CEO Effective Date: August 12, 2026 CEO Retirement Date: August 11, 2026 Prior CEO Tenure: more than seven years +3 more
6 metrics
Interim CEO Effective Date August 12, 2026 Lionel Conacher’s appointment
CEO Retirement Date August 11, 2026 Harvey Kanter’s retirement
Prior CEO Tenure more than seven years Harvey Kanter served as CEO
Board Service since June 2018 Lionel Conacher’s DXL Board service
Chairman Service since August 2020 Lionel Conacher’s DXL Chairman service
Prior Interim CEO Role September 2022 to May 2023 Conacher’s service at SRx Health Solutions, Inc.

Historical Context

5 past events · Latest: Jul 20 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 20 Merger proxy filing Positive -2.6% Board recommended voting against merger share issuance after reassessing dilution and FullBeauty’s financial position.
Jul 08 Tender offer rejection Positive +0.7% Board recommended rejecting Zodiac Partners’ revised $0.84-per-share cash tender offer.
Jun 23 Tender offer review Neutral -2.8% DXL began reviewing Zodiac Partners II’s revised $0.84-per-share unsolicited tender offer.
Jun 03 Merger update Negative -1.5% Board cited tougher consumer conditions and FullBeauty indebtedness in questioning merger terms.
Jun 03 First-quarter earnings Negative -1.5% Sales declined 2.1% year over year while DXL reported a $5.9 million net loss.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

DXLG’s recent reactions generally aligned with the direction of company news, while merger-related announcements produced mixed signals.

Key Terms

glp-1, m&a, proxy statement, tender offer
4 terms
glp-1 medical
"advancing our key strategic priorities – our FiTMAP rollout, investing in AI and responding to increasing GLP-1 usage"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.
m&a financial
"Lionel has significant M&A experience that will help us navigate both the FullBeauty merger transaction"
M&A, short for mergers and acquisitions, involves one company combining with or purchasing another company to grow, streamline operations, or gain competitive advantages. For investors, M&A activity can signal potential for increased value, new opportunities, or changes in market dynamics, making it an important factor to watch in the business landscape.
View in glossary
proxy statement regulatory
"DXL has filed a preliminary proxy statement and intends to file a definitive proxy statement"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
View in glossary
tender offer financial
"the unsolicited tender offer by Zodiac Partners II, LLC"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (“DXL” or the “Company”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today announced that Lionel Conacher, Chairman of the DXL Board of Directors, has been named Interim Chief Executive Officer, effective August 12, 2026. Mr. Conacher will continue in his role as Chairman of the DXL Board. Mr. Conacher’s appointment follows the previously announced retirement of Harvey Kanter, effective August 11, 2026. Mr. Kanter will also step down from the Board at that time.

“I am honored to take on the role of Interim CEO at an important time for DXL,” Mr. Conacher said. “We are executing a clear strategy to return the Company to profitability against a challenging market backdrop, taking decisive action to reduce our cost structure and evolve our assortment, promotional strategy and customer experience to better meet the needs of our consumer today. I look forward to working alongside our talented leadership team to continue building on the success of these efforts to date and advancing our key strategic priorities – our FiTMAP rollout, investing in AI and responding to increasing GLP-1 usage – to bolster our strong foundation for future growth.”

“Our Board will conduct a thorough search to identify the right leader to execute on our strategic priorities and capture the opportunities ahead in a dynamic consumer environment,” Mr. Conacher continued. “On behalf of the Board, I want to thank Harvey for his leadership and invaluable contributions to the Company during his more than seven years as CEO. We wish him all the best in his well-earned retirement.”

“It has been a privilege to lead the DXL team, and I am incredibly proud of the progress we have made in advancing our vision of redefining the way our industry approaches inclusive fashion,” said Mr. Kanter. “Together, we have established DXL as the leading specialty retailer in Men’s Big + Tall and built a platform that is well-positioned for future success. Lionel has significant M&A experience that will help us navigate both the FullBeauty merger transaction and Zodiac Partners’ unsolicited tender offer in the near term. He also has a deep understanding of our business. I am confident he is the right leader to guide DXL in this transition period and as we prepare for our next phase of growth.”

In connection with his appointment, Mr. Conacher will step down as Chair of the Audit Committee and as a member of the Compensation Committee. In accordance with the Company’s Corporate Governance Guidelines, Carmen Bauza has been appointed Lead Independent Director.

About Lionel Conacher

Mr. Conacher has served on DXL’s Board of Directors since June 2018 and as Chairman since August 2020. He currently serves on the board of directors of Metatek-Group Ltd., where he chairs the Governance and Nomination Committee. From 2021 to 2025, he served as a director of SRx Health Solutions, Inc., including as Interim Chief Executive Officer from September 2022 to May 2023. Previously, Mr. Conacher served as Managing Partner of Next Ventures, Senior Advisor to private equity firm Altamont Capital Partners and President and Chief Operating Officer of investment bank Thomas Weisel Partners. He also served as Chairman of Wunderlich Securities, an Altamont portfolio company.

Mr. Conacher received a BA in Economics and Art History from Dartmouth College.

About Destination XL Group, Inc.
Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, and an e-commerce website, DXL.COM, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. DXL is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Global Market under the symbol “DXLG.” For more information, please visit DXL’s investor relations website: https://investor.dxl.com.

Important Information about the Merger and Where to Find It
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This communication may be deemed to be solicitation material in respect of the proposed merger (the “Merger”) between DXL and FBB Holdings I, Inc. (“FullBeauty”). In connection with the Merger, DXL has filed a preliminary proxy statement and intends to file a definitive proxy statement (the “Proxy Statement”), which will be distributed to the stockholders of DXL in connection with their votes on the issuance of DXL Common Stock in the Merger. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT (AND ANY OTHER DOCUMENTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) IN CONNECTION WITH THE MERGER OR INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT) BECAUSE SUCH DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION REGARDING THE MERGER AND RELATED MATTERS. Investors and security holders will be able to obtain these documents, and any other documents DXL has filed with the SEC, free of charge at the SEC’s website, www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

Participants in the Solicitation
DXL and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about DXL’s directors and executive officers, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in DXL’s Annual Report on Form 10-K/A, which was filed with the SEC on May 26, 2026, including under the headings “Director Compensation,” “Compensation Discussion and Analysis,” “Executive Compensation,” and “Security Ownership of Management,” and in the Proxy Statement, which was filed with the SEC on July 17, 2026, including under the headings “Merger—Interests of DXL’s Directors and Executive Officers in the Merger,” “DXL’s Executive Compensation,” “Executive Officers and Directors Following the Merger” and “Principal Stockholders of DXL.” To the extent holdings of DXL Common Stock by the directors and executive officers of DXL have changed from the amounts of DXL Common Stock held by such persons as reflected therein, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership of Securities on Form 5, in each case filed with the SEC, including the Form 4s filed by each of the non-executive directors on August 6, 2025, the Form 4s filed by each of the executive officers on September 3, 2025, the Form 4s filed by each of the non-executive directors on November 5, 2025, the Form 4s filed by each of the non-executive directors on February 4, 2026, the Form 4s filed by each of the executive officers on April 3, 2026, the Form 4s filed by each of the non-executive directors on May 6, 2026 and the Form 4s filed by each of the non-executive directors on August 5, 2026.

FullBeauty and its chief executive officer may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about FullBeauty and its chief executive officer can be found in the Form 8-K filed by DXL with the SEC on December 11, 2025 and in the Proxy Statement filed by DXL with the SEC on July 17, 2026, including under the heading “Executive Officers and Directors Following the Merger.”

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the Proxy Statement regarding the Merger. Free copies of this document may be obtained as described above.

Important Information about the Zodiac Partners Tender Offer and Where to Find It
INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE SOLICITATION/RECOMMENDATION STATEMENT, AS AMENDED, AND ANY OTHER RELEVANT DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE UNSOLICITED TENDER OFFER BY ZODIAC PARTNERS II, LLC (“ZODIAC PARTNERS”). Investors and security holders may obtain free copies of the solicitation/recommendation statement, and any amendments thereto (when available), as well as other filings by DXL, without charge, at the SEC’s website, http://www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

Forward-Looking Statements
Certain statements and information contained in this press release constitute forward-looking statements under the federal securities laws, including statements regarding DXL’s execution of a clear strategy to return the Company to profitability against a challenging market backdrop, taking decisive action to reduce its cost structure and evolving its assortment, promotional strategy and customer experience to better meet the needs of its consumer today; DXL’s key strategic priorities – its FiTMAP rollout, investing in AI and responding to increasing GLP-1 usage – to bolster its strong foundation for future growth; the Board’s plan to conduct a thorough search to identify the right leader to execute on DXL’s strategic priorities and capture the opportunities ahead in a dynamic consumer environment; and the belief that DXL has built a platform that is well-positioned for future success; confidence that Mr. Conacher is the right leader to guide DXL in this transition period and as it prepares for its next phase of growth.

The discussion of forward-looking information requires the management of DXL to make certain estimates and assumptions regarding DXL’s strategic direction and the effect of such plans on DXL’s financial results. DXL’s actual results and the implementation of its plans and operations may differ materially from forward-looking statements made by DXL. DXL encourages readers of forward-looking information concerning DXL to refer to its filings with the Securities and Exchange Commission, including without limitation, its Annual Report on Form 10-K filed on March 19, 2026, its Amendment No. 1 to Annual Report on Form 10-K/A filed on May 26, 2026, its Preliminary Proxy Statement on Schedule 14A filed on July 17, 2026, its Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission that set forth certain risks and uncertainties that may have an impact on future results and the direction of DXL, including risks relating to changes in consumer spending in response to economic factors; the impact of inflation with rising costs and high interest rates; the impact of tariffs; the impact of ongoing worldwide conflicts on the global economy; potential labor shortages; DXL’s ability to grow its market share, predict customer tastes and fashion trends, forecast sales growth trends, and compete successfully in the U.S. men’s big and tall apparel market; and the proposed merger with FullBeauty Brands.

Forward-looking statements contained in this press release speak only as of the date of this release. Subsequent events or circumstances occurring after such date may render these statements incomplete or out of date. DXL undertakes no obligation and expressly disclaims any duty to update such statements, except as otherwise required by applicable law.

Investor Contact:
Investor.relations@dxlg.com
603-933-0541

Media Contact:
Aaron Palash / Michael Reilly / Carly King
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449


FAQ

Who is the new interim CEO of Destination XL Group (NASDAQ: DXLG)?

Destination XL appointed Board Chairman Lionel Conacher as Interim CEO effective August 12, 2026. According to Destination XL, Conacher will also remain Chairman while leading execution of its profitability strategy and overseeing activities related to the proposed FullBeauty merger and Zodiac Partners’ unsolicited tender offer.

When is Harvey Kanter retiring from Destination XL Group (DXLG)?

Harvey Kanter will retire as CEO of Destination XL on August 11, 2026, and leave the Board. According to Destination XL, his departure triggers the transition to Interim CEO Lionel Conacher as the company continues executing strategic initiatives and managing ongoing transaction processes.

How does the FullBeauty merger relate to Destination XL Group (DXLG) leadership changes?

Destination XL states that Interim CEO Lionel Conacher’s M&A experience will help navigate the proposed FullBeauty merger. According to Destination XL, stockholders should review the proxy statement filed with the SEC for detailed information on the merger terms, voting process and related matters.

What is the Zodiac Partners unsolicited tender offer for Destination XL (DXLG) shareholders?

Destination XL refers to an unsolicited tender offer by Zodiac Partners II, LLC for its shares. According to Destination XL, investors should read the filed solicitation/recommendation statement and related SEC documents for important information before making any decision regarding the tender offer.

What governance changes did Destination XL (DXLG) announce on August 6, 2026?

Destination XL announced that Lionel Conacher will step down as Audit Committee Chair and Compensation Committee member. According to Destination XL, the Board also appointed Carmen Bauza as Lead Independent Director in accordance with the company’s Corporate Governance Guidelines.

What strategic priorities did Destination XL (DXLG) highlight with the interim CEO appointment?

Destination XL emphasized returning to profitability, cost reductions and evolving its assortment and customer experience. According to Destination XL, key priorities include its FiTMAP rollout, investing in AI and responding to increasing GLP‑1 usage to support a foundation for future growth.